financetom
Business
financetom
/
Business
/
Corpay quarterly profit rises on corporate payments strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Corpay quarterly profit rises on corporate payments strength
May 7, 2026 2:49 PM

May 7 (Reuters) - Business payments firm Corpay ( CPAY )

reported a jump in first-quarter adjusted profit on Thursday,

driven by growth in its corporate and vehicle payments segments.

* Corpay's ( CPAY ) corporate payments business, which automates and

manages vendor payments, saw quarterly revenue grow 46% from a

year earlier to $503.9 million.

* The vehicle payments segment saw quarterly net revenue

jump 19% from a year earlier to $563.9 million, while total

revenue surged 25% to $1.26 billion.

* The segment benefited from higher fuel prices during the

period, which lifted transaction values and fee income.

* On an adjusted basis, Corpay ( CPAY ) reported a quarterly profit

of $397.2 million, or $5.80 per share, compared to $322.9

million, or $4.51 per share, a year earlier.

* "We are raising our full-year outlook as a result of our

first-quarter over-performance, the expected higher rest-of-year

fuel prices and our first-quarter fundamental trends running

ahead of our expectations," said Peter Walker, the company's

finance chief.

* Annual revenue is now expected between $5.25 billion and

$5.33 billion, compared with its prior forecast of $5.22 billion

and $5.32 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol Myers liver cancer treatment meets main goal of late-stage study
Bristol Myers liver cancer treatment meets main goal of late-stage study
Mar 20, 2024
March 20 (Reuters) - Bristol Myers Squibb ( BMY ) said on Wednesday a combination of its drugs, Opdivo and Yervoy, met the main goal of a late-stage study evaluating it as a first-line treatment for a type of liver cancer. (Reporting by Puyaan Singh) ...
BioNTech Q4 Earnings, Revenue Fall; Sets 2024 Revenue Guidance -- Shares Drop Premarket
BioNTech Q4 Earnings, Revenue Fall; Sets 2024 Revenue Guidance -- Shares Drop Premarket
Mar 20, 2024
07:01 AM EDT, 03/20/2024 (MT Newswires) -- BioNTech (BNTX) reported Q4 earnings Wednesday of 1.90 euro ($2.06) per diluted share, down from 9.26 euros a year earlier. Analysts polled by Capital IQ expected 2.65 euros. Revenue for the quarter ended Dec. 31 was 1.48 billion euros, down from 4.28 billion euros a year earlier. Analysts surveyed by Capital IQ expected...
Tencent Music beats quarterly revenue estimates (March 19)
Tencent Music beats quarterly revenue estimates (March 19)
Mar 20, 2024
HONG KONG, March 19 (Reuters) - China's Tencent Music Entertainment Group ( TME ) beat fourth-quarter revenue estimates on Tuesday, driven by growth in paid subscription on its Spotify ( SPOT )-like music streaming platform. The audio entertainment platform reported revenue of 6.89 billion yuan ($957.06 million) for the quarter, marking a 7.2% decline as compared to the same period...
General Mills posts smaller-than-expected drop in quarterly sales
General Mills posts smaller-than-expected drop in quarterly sales
Mar 20, 2024
March 20 (Reuters) - Cheerios maker General Mills ( GIS ) posted a smaller-than-expected drop in quarterly sales on Wednesday, backed by higher prices for its breakfast cereals, snack bars and pet food products that helped cushion a blow from slowing demand. The Cheerios cereal maker's net sales dropped about 1% to $5.1 billion in the third quarter, compared with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved